For the Inventor, By the Inventor

Enter assignee name

Maharashtra, India

Reliance Life Sciences Pvt. Ltd.

USPTO Granted Patents = 31

% Expired Patents = 90.3

EPO Patents = 10

Forward Citations = 109

Loading Chart...

Loading Chart...

79 inventors (with patents filed for the assignee):

Vidhya Rangaswamy (4 out of 6 patents)

Geeta Ravindran (3 out of 4 patents)

Murali Krishna Addepalli (3 out of 3 patents)

4. Vidyadhar Eswar Chandra Gopavaram Reddy (2 out of 2 patents)

5. Ghanshyam Maurya (2 out of 2 patents)

6. Chandra Viswanathan (2 out of 2 patents)

7. Deepa Ghosh (2 out of 2 patents)

8. Anil Kush Kumar (2 out of 2 patents)

9. Debasis Patnaik (2 out of 2 patents)

10. Shabari Pradeep Tipnis (2 out of 2 patents)

11. Uma Sankar Satpathy (1 out of 11 patents)

12. Pralhad Ambadas Ganeshpure (1 out of 2 patents)

13. Saurabh Saran (1 out of 1 patent)

14. Meikandhan Thiru (1 out of 1 patent)

15. Mithra Kannabiran (1 out of 1 patent)

Core Competencies:

Biodiesel Production

Biobutanol

Tetrazine Derivatives

Dopaminergic Neurons

RNAi Therapy

Tissue Engineering

Stem Cell Lines

GABAergic Neurons

Polylactic Acid

Haemopoietic Stem Cells

Therapeutic Uses

31 patents: Sort by Forward Citations

1. 9725745 - Process for biodiesel production from a yeast strain (2017-08-08),

2. 9217163 - Process for production and quantitation of high yield of biobutanol (2015-12-22),

3. 8716471 - Process for the preparation of tetrazine derivatives (2014-05-06),

4. 8481768 - Integrated process for the preparation of fatty acid methyl ester (biodiesel) (2013-07-09),

5. 8338175 - Conjunctival tissue system (2012-12-25),

6. 8304239 - [object Object] (2012-11-06),

7. 8188264 - RNAi mediated knockdown of NuMA for cancer therapy (2012-05-29),

8. 8187875 - Dopaminergic neurons derived from corneal limbus, methods of isolation and uses thereof (2012-05-29),

9. 8026225 - Short nucleic acid molecule-mediated modulation of Aurora B kinase expression and combinations for use in anticancer therapy (2011-09-27),

10. 7993922 - Three-dimensional tissue equivalent using macromass culture (2011-08-09),

11. 7932086 - [object Object] (2011-04-26),

12. 7897388 - Growth of neural precursor cells using umbilical cord blood serum and a process for the preparation for therapeutic purposes (2011-03-01),

13. 7879584 - [object Object] (2011-02-01),

14. 7846699 - [object Object] (2010-12-07),

15. 7820439 - In vitro generation of GABAergic neurons from pluripotent stem cells (2010-10-26),

Company Overview

Reliance Life Sciences Pvt. Ltd., based in Maharashtra, India, is a prominent player in the life sciences sector, focusing on biotechnology and healthcare solutions. The company specializes in the development and manufacturing of biopharmaceuticals, biosimilars, and regenerative medicine products. With a commitment to innovation, Reliance Life Sciences engages in extensive research across various domains, including molecular biology, cell therapy, and diagnostics, aiming to enhance healthcare outcomes and address unmet medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

31 Patents

#1 in Maharashtra

#65 in India

#21,284 in the World

Maharashtra, India

Reliance Life Sciences Pvt. Ltd.

Forward Citations = 109

79 inventors:

Vidhya Rangaswamy (4 out of 6 patents)

Geeta Ravindran (3 out of 4 patents)

Murali Krishna Addepalli (3 out of 3 patents)

4. Vidyadhar Eswar Chandra Gopavaram Reddy (2 out of 2 patents)

5. Ghanshyam Maurya (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Reliance Life Sciences Pvt. Ltd.. Retrieved from https://idiyas.com/company/reliance-life-sciences-pvt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…